key: cord-1025948-0479vbt0
authors: Van Elslande, Jan; Vermeersch, Pieter; Vandervoort, Kris; Wawina-Bokalanga, Tony; Vanmechelen, Bert; Wollants, Elke; Laenen, Lies; André, Emmanuel; Van Ranst, Marc; Lagrou, Katrien; Maes, Piet
title: Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain
date: 2020-09-05
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa1330
sha: 2ef6c3e763e4567dd65aaefa9437ee8211a18e66
doc_id: 1025948
cord_uid: 0479vbt0

nan

M a n u s c r i p t 2 Dear editor:

To et al. reported the first documented case of a asymptomatic reinfection with SARS-CoV-2 after 4.5 months [1] . As the patient experienced only mild symptoms during the first episode, the question remains whether a weak immune response after the first episode might explain the reinfection. It has been suggested that patients with an asymptomatic or mild SARS-CoV-2 infection have a weaker immune response since their antibody titers are significantly lower than in patients with pneumonia [2] . An estimated 20% do not seroconvert [3] . It also remains unclear whether patients can have a symptomatic reinfection. A recent Italian study reported no clinical reinfections within 3 months after hospital discharge [4] . We here report a symptomatic reinfection 93 days after a moderate SARS-CoV-2 infection.

In March 2020, a 51-year-old women presented to the general practitioner symptoms of headache, fever, myalgia, coughing, chest pain and dyspnea. She also mentioned anosmia and a change in taste. She was not immunocompromised, but took a daily dose of inhaled corticosteroids for asthma. A nasopharyngeal swab tested positive with SARS-CoV-2 PCR.

Routine biochemistry and complete blood count did not show any abnormalities besides mildly elevated liver enzymes. Oxygen saturation by capillary oximeter was 94%.

Hospitalisation was not deemed necessary at the time and the patient was asked to selfquarantine for 2 weeks. Because of persisting symptoms of tiredness, muscle pains and dyspnoe, she stayed at home for 5 weeks before returning to work.

Three months after initial onset of symptoms, she experienced a relapse of symptoms with headache, cough and fatigue. Rhinitis was also present. There was no travel history.

The patient told the general practitioner that the symptoms felt similar to the first episode in March, although milder. The nasopharyngeal swab was again positive for SARS-CoV-2, suggesting a reinfection ( Table 1 ). The symptoms resolved after one week. At that time, the patient tested positive for anti-SARS-CoV-2 nucleocapsid antibodies (Roche total Ig signal/cut-off 134).

Full-length genome sequencing with ONT MinION revealed that the initial infection was caused by a lineage B.1.1 SARS-CoV-2 virus and the relapsing infection by a lineage A [5] . Eleven mutations were identified across the genome of the two strains (11/29903 A c c e p t e d M a n u s c r i p t 3 differences, 99.7% identity; Table 1 ). This difference is in line with other circulating strains in Belgium [6] . Documenting reinfection requires full-length genome sequencing or viral culture as PCR can remain positive for up to 104 days [7] . Usually asymptomatic and mild cases exhibit longer RNA shedding than severe cases [2] .

The fact that a symptomatic reinfection with SARS-CoV-2 can occur already 3 months after the first infection is not unexpected. Symptomatic reinfections with human non-SARS coronaviruses are common and not atypical within 1 year after initial infection, despite the presence of antibodies. Reinfections with human non-SARS coronaviruses are, however, typically milder as was the case in our patient [8] [9] [10] nomenclature based on reference [5] 

COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: a prospective longitudinal study

Clinical Immunity in Discharged Medical Patients with COVID 19

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

CoV-2 resources

Prolonged Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in an Obstetric Patient With Antibody Seroconversion

Direct Observation of Repeated Infections With Endemic Coronaviruses

The time course of the immune response to experimental coronavirus infection of man

Rises in titers of antibody to human corona viruses oc43 and 229e in seattle families during 1975-1979

A c c e p t e d M a n u s c r i p t 5